GlassScriptPhysician profile
Mauna B Pandya
NPI 1356439178
$17,556.11
in general payments reported to CMS, 2019-2025
95 companies · $3,684 in 2025
The $3,684 reported for 2025 was more than what 78% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,723 · 2020: $635 · 2021: $1,725 · 2022: $2,613 · 2023: $3,399 · 2024: $3,779 · 2025: $3,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $277.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,583.73 |
| Education | $276.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,239.40 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $1,123.34 | 2019-2025 | Keytruda, Lynparza, Reblozyl |
| Janssen Biotech, INC. | $947.63 | 2019-2025 | Erleada, Darzalex, Tecvayli |
| E.R. Squibb & Sons, L.L.C. | $881.54 | 2019-2024 | Opdivo, Opdualag, Eliquis |
| Astrazeneca Pharmaceuticals LP | $784.19 | 2019-2025 | Calquence, Lynparza, Enhertu |
| Celgene Corporation | $679.54 | 2019-2025 | Reblozyl |
| Pfizer INC. | $674.48 | 2019-2025 | |
| Lilly USA, LLC | $563.51 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Genentech USA, INC. | $563.09 | 2019-2025 | Venclexta, Phesgo, Itovebi |
| Gilead Sciences, INC. | $515.98 | 2021-2025 | Trodelvy |
| Eisai INC. | $504.54 | 2019-2025 | |
| Amgen INC. | $416.72 | 2019-2023 | Kyprolis, Blincyto |
| Takeda Pharmaceuticals U.S.A., INC. | $412.08 | 2019-2025 | Ninlaro, Fruzaqla, Alunbrig |
| Daiichi Sankyo INC. | $385.90 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Glaxosmithkline, LLC. | $372.41 | 2021-2025 | Jemperli, Zejula, Ojjaara |
Show all 95 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $353.04 | 2019-2025 | Padcev, Xtandi |
| Alexion Pharmaceuticals, INC. | $341.40 | 2021-2025 | Ultomiris |
| Abbvie INC. | $336.06 | 2019-2025 | |
| Ipsen Biopharmaceuticals, INC | $332.71 | 2019-2024 | Onivyde, Tazverik, Somatuline Depot |
| Genzyme Corporation | $297.29 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $296.30 | 2022-2025 | Libtayo |
| Incyte Corporation | $257.73 | 2019-2025 | Jakafi, Zynyz, Monjuvi |
| Seagen INC. | $247.30 | 2019-2025 | Padcev, Tukysa |
| Ge Healthcare | $221.86 | 2021-2025 | |
| Beigene USA, INC. | $206.19 | 2022-2025 | Brukinsa, Tevimbra |
| Jazz Pharmaceuticals INC. | $190.20 | 2020-2025 | |
| Octapharma USA, INC. | $177.17 | 2023 | Octagam Immune Globulin (Human) |
| Dova Pharmaceuticals | $177.16 | 2020-2021 | |
| Global Blood Therapeutics, INC. | $157.90 | 2020-2022 | |
| Exelixis INC. | $148.65 | 2019-2024 | Cabometyx |
| Agios Pharmaceuticals, INC. | $147.75 | 2022-2025 | Pyrukynd |
| Janssen Pharmaceuticals, INC | $146.06 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $142.81 | 2019-2025 | |
| Tersera Therapeutics LLC | $139.38 | 2024-2025 | Zoladex |
| Pharmacyclics LLC, An Abbvie Company | $129.17 | 2019-2023 | Imbruvica |
| Emd Serono, INC. | $128.60 | 2019-2024 | Tepmetko, Bavencio |
| Pharmacosmos Therapeutics INC. | $123.83 | 2022-2025 | Monoferric, Cosela |
| Puma Biotechnology, INC. | $116.11 | 2019-2024 | |
| Coherus Oncology, INC. | $115.76 | 2022-2023 | |
| Deciphera Pharmaceuticals INC. | $108.93 | 2022-2025 | Qinlock, Romvimza |
| Morphosys, US INC. | $107.36 | 2021-2023 | Monjuvi |
| Myriad Genetic Laboratories, INC. | $100.40 | 2022-2023 | Myrisk |
| G1 Therapeutics, INC. | $98.82 | 2022-2023 | Cosela |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.61 | 2019-2025 | |
| Karyopharm Therapeutics INC. | $90.16 | 2023-2025 | Xpovio |
| Novo Nordisk INC | $87.86 | 2019-2023 | |
| Kite Pharma, INC. | $87.49 | 2021-2025 | Yescarta |
| Mirati Therapeutics, INC. | $81.84 | 2023-2024 | Krazati |
| Servier Pharmaceuticals LLC | $74.93 | 2022-2025 | |
| Foundation Medicine, INC. | $73.69 | 2021-2023 | |
| Fresenius Kabi USA, LLC | $71.03 | 2023-2024 | Stimufend |
| Geron Corporation | $67.63 | 2025 | Rytelo |
| Tempus Ai, INC | $66.95 | 2024-2025 | Xt Cdx |
| Rigel Pharmaceuticals, INC. | $65.36 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Stemline Therapeutics INC. | $60.06 | 2025 | Orserdu |
| Pharmaessentia USA Corporation | $60.03 | 2025 | Besremi |
| Genmab U.S., INC. | $57.98 | 2023 | Epkinly |
| Adc Therapeutics America, INC. | $54.24 | 2024-2025 | |
| Clovis Oncology, INC. | $53.38 | 2019-2020 | |
| Sobi, INC | $51.96 | 2022 | |
| Blueprint Medicines Corporation | $51.81 | 2023-2024 | Ayvakit |
| Taiho Oncology, INC. | $51.49 | 2019-2024 | |
| Aveo Pharmaceuticals, INC. | $48.20 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $44.72 | 2023-2024 | Orgovyx |
| Iovance Biotherapeutics, INC. | $42.14 | 2025 | Amtagvi |
| Teva Pharmaceuticals USA, INC. | $38.39 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $34.31 | 2025 | Provenge |
| Array Biopharma INC | $31.19 | 2024-2025 | Mektovi, Tukysa, Braftovi |
| Tactile Systems Technology INC | $30.92 | 2019-2025 | Nimbl, Flexitouch Plus |
| Azurity Pharmaceuticals, INC. | $29.69 | 2025 | Vivimusta, Danziten |
| Springworks Therapeutics, INC. | $29.21 | 2025 | Ogsiveo |
| Beone Medicines USA, INC. | $27.82 | 2025 | Brukinsa |
| Biocon Biologics INC | $27.69 | 2025 | Fulphila |
| Pharmaand Gmbh | $27.44 | 2025 | Rubraca |
| Adaptive Biotechnologies Corporation | $26.01 | 2025 | Clonoseq |
| Amneal Pharmaceuticals LLC | $25.98 | 2024 | Avastin |
| Immunocore Limited | $25.05 | 2024 | Kimmtrak |
| Recordati_rare_diseases_inc. | $24.89 | 2023 | Sylvant |
| Spectrum Pharmaceuticals INC. | $24.87 | 2024 | Rolvedon |
| Secura Bio, INC. | $23.63 | 2023 | Copiktra |
| Myovant Sciences INC. | $23.25 | 2022 | |
| Legend Biotech USA INC. | $23.22 | 2025 | Carvykti |
| Immunogen, INC. | $22.05 | 2024 | Elahere |
| Sun Pharmaceutical Industries INC. | $21.84 | 2019 | |
| Apellis Pharmaceuticals, INC. | $21.38 | 2024 | Empaveli |
| Blue Earth Diagnostics | $20.07 | 2024 | |
| Verastem, INC. | $19.87 | 2020 | |
| Fennec Pharmaceuticals, INC. | $19.44 | 2024 | Pedmark |
| Accord Healthcare, INC. | $19.21 | 2025 | |
| Tolmar Pharmaceuticals, INC. | $18.74 | 2022 | |
| Progenics Pharmaceuticals, INC. | $17.24 | 2023 | Pylarify |
| Kyowa Kirin, INC. | $14.48 | 2019 | |
| Tolmar, INC. | $14.29 | 2025 | Rubraca, Eligard |
| Amag Pharmaceuticals, INC. | $12.80 | 2021 | |
| Sysmex Inostics INC | $12.29 | 2019 |
Drugs and devices associated with these payments
Reblozyl $521Keytruda $468Kisqali $448Opdivo $354Lynparza $303Libtayo $280Lenvima $264Padcev $261Verzenio $248Venclexta $210Enhertu $207Ultomiris $192Imbruvica $185Ibrance $181Brukinsa $178Octagam Immune Globulin (Human) $177Trodelvy $175Erleada $174Tukysa $168Epkinly $166Jaypirca $163Jemperli $150Zejula $150Zoladex $139Retevmo $136Onivyde $128Darzalex $127Fabhalta $118Ninlaro $116Zepzelca $115Pyrukynd $114Sarclisa $102Calquence $101Cosela $95.68Lutathera $95.17Jakafi $94.85Tecvayli $92.82Xpovio $90.16Scemblix $85.92Qinlock $83.97Krazati $81.84Injectafer $81.78Adcetris $81.28Elrexfio $81.28Piqray $80.06Elahere $79.83Orgovyx $75.83Phesgo $72.38Stimufend $71.03Ayvakit $69.16Rytelo $67.63Cabometyx $66.17Bosulif $65.93Tasigna $65.20Udenyca $64.63Itovebi $62.18Ojjaara $62.05Nubeqa $60.80Xofigo $60.80Talvey $60.33Orserdu $60.06Besremi $60.03Xtandi $59.32Imfinzi $58.02Fruzaqla $58.00Tibsovo $57.86Rybrevant $57.53Monoferric $56.57Carvykti $55.12Pluvicto $54.73Alunbrig $54.49Mektovi $52.83Braftovi $52.83Kyprolis $52.09Tepmetko $50.76Fotivda $48.20Inlyta $46.11Lunsumio $45.77Columvi $45.77Polivy $45.77Blincyto $44.95Lorbrena $44.19Monjuvi $44.05Emrelis $43.35Bavencio $42.37Amtagvi $42.14Mekinist $41.88Rubraca $41.73Oxbryta $40.68Paxlovid $38.48Yescarta $37.80Welireg $35.71Provenge $34.31Shingrix $33.79Balversa $31.65Talzenna $31.11Danziten $29.69Vivimusta $29.69Eliquis $29.46Ogsiveo $29.21
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mauna Pandya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.